Supernus Pharmaceuticals reported 72.26 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
Abbott 34.85 10.99 Sep/2026
ANI Pharmaceuticals 15.46 8.81 Sep/2026
Aurora Cannabis 23.27 0 Mar/2026
Bristol-Myers Squibb 10.44 5.7 Sep/2026
Cara Therapeutics 0.49 27.28 Mar/2026
Corcept Therapeutics 86.2 102.04 Sep/2026
Eisai 30.24 3.68 Sep/2026
Eli Lilly 64.5 31.61 Sep/2026
Novo Nordisk 10.17 2.61 Jun/2026
Pacira 80.9 45.22 Sep/2026
Perrigo 21.11 6.34 Sep/2026
Pfizer 15.2 3.72 Sep/2026
Supernus Pharmaceuticals 72.26 6.89 Sep/2026
United Therapeutics 19.41 0.26 Sep/2026
Xeris Pharmaceuticals 92.28 16.23 Jun/2026